Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraocular methotrexate for uveitis: safety and efficacy
2006-006728-20Phase 4Terminated
- Sponsor
- Moorfields Eye Hospital
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in uveitis, sponsored by Moorfields Eye Hospital. Started Apr 2007; status: terminated.
02
Drugs
methotrexate
03
Conditions
uveitis
Beyond the preview
Go deeper on 2006-006728-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006728-20.